Literature DB >> 32138968

Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.

Andrea Rodrigues Sabbatini1, Georgios Kararigas2.   

Abstract

Heart failure (HF) is a complex condition affecting >40 million people worldwide. It is defined by failure of the heart to pump (HF with reduced ejection fraction) or by the failure of the heart to relax, resulting in reduced filling but with preserved ejection fraction (HFpEF). HFpEF affects approximately 50% of patients with HF, most of whom are women. Given that the annual mortality ranges from 10% to 30% and as there are no treatments specifically directed for HFpEF, there is a need for better understanding of the underlying mechanisms of this condition. We put forward the hypothesis that the decline of estrogen at menopause might contribute to the pathogenesis of HFpEF and we highlight potential underlying mechanisms of estrogen action, which may attenuate the development of HFpEF. We also discuss areas in which additional research is needed to develop new approaches for prevention and treatment of HFpEF.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  17β-estradiol; cardiac function; heart failure; hormone therapy; molecular mechanisms; postmenopausal

Mesh:

Substances:

Year:  2020        PMID: 32138968     DOI: 10.1016/j.jacc.2019.12.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

1.  On the search for the right definition of heart failure with preserved ejection fraction.

Authors:  Agnieszka Kapłon-Cieślicka; Karolina Kupczyńska; Piotr Dobrowolski; Błażej Michalski; Miłosz J Jaguszewski; Waldemar Banasiak; Paweł Burchardt; Łukasz Chrzanowski; Szymon Darocha; Justyna Domienik-Karłowicz; Jarosław Drożdż; Marcin Fijałkowski; Krzysztof J Filipiak; Marcin Gruchała; Ewa A Jankowska; Piotr Jankowski; Jarosław D Kasprzak; Wojciech Kosmala; Piotr Lipiec; Przemysław Mitkowski; Katarzyna Mizia-Stec; Piotr Szymański; Agnieszka Tycińska; Wojciech Wańha; Maciej Wybraniec; Adam Witkowski; Piotr Ponikowski; On Behalf Of "Club 30" Of The Polish Cardiac Society
Journal:  Cardiol J       Date:  2020-09-28       Impact factor: 2.737

2.  Menopausal age and left ventricular remodeling by cardiac magnetic resonance imaging among 14,550 women.

Authors:  Michael C Honigberg; James P Pirruccello; Krishna Aragam; Amy A Sarma; Nandita S Scott; Malissa J Wood; Pradeep Natarajan
Journal:  Am Heart J       Date:  2020-08-20       Impact factor: 4.749

Review 3.  Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction.

Authors:  Dane Rucker; Jacob Joseph
Journal:  Curr Heart Fail Rep       Date:  2022-09-30

4.  Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity.

Authors:  Bochra Tourki; Vasundhara Kain; Saame Raza Shaikh; Xavier Leroy; Charles N Serhan; Ganesh V Halade
Journal:  FASEB J       Date:  2020-06-16       Impact factor: 5.191

5.  Sex differences in the incidence and mode of death in rats with heart failure with preserved ejection fraction.

Authors:  Khaled Elkholey; Lynsie Morris; Monika Niewiadomska; Jeremy Houser; Michelle Ramirez; Mulan Tang; Mary Beth Humphrey; Stavros Stavrakis
Journal:  Exp Physiol       Date:  2021-01-19       Impact factor: 2.969

6.  A novel assay to assess the effects of estrogen on the cardiac calmodulin binding equilibrium.

Authors:  Kyle Kaster; John Patton; Sarah Clayton; Eric Wauson; Jennifer Giles; Quang-Kim Tran
Journal:  Life Sci       Date:  2021-12-23       Impact factor: 5.037

7.  Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.

Authors:  Jennifer J DuPont; Seung Kyum Kim; Rachel M Kenney; Iris Z Jaffe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-23       Impact factor: 4.733

8.  Adjuvant Hormonotherapy and Cardiovascular Risk in Post-Menopausal Women with Breast Cancer: A Large Population-Based Cohort Study.

Authors:  Matteo Franchi; Roberta Tritto; Luigi Tarantini; Alessandro Navazio; Giovanni Corrao
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

9.  Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure-Results From the MyoVasc Study.

Authors:  Bianca Dahlen; Felix Müller; Sven-Oliver Tröbs; Marc William Heidorn; Andreas Schulz; Natalie Arnold; M Iris Hermanns; Sören Schwuchow-Thonke; Jürgen H Prochaska; Tommaso Gori; Hugo Ten Cate; Karl J Lackner; Thomas Münzel; Philipp S Wild; Marina Panova-Noeva
Journal:  Front Cardiovasc Med       Date:  2021-06-16

Review 10.  Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress.

Authors:  Du Xiang; Yang Liu; Shujun Zhou; Encheng Zhou; Yanfeng Wang
Journal:  Oxid Med Cell Longev       Date:  2021-06-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.